Karen Deborah Chagin's most recent trade in Context Therapeutics Inc was a trade of 153,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Context Therapeutics Inc | Karen Deborah Chagin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 153,000 | 153,000 | - | - | Stock Option (right to buy) |